TY - JOUR
T1 - How Least Developed to Lower-Middle Income Countries Use Health Technology Assessment
T2 - A Scoping Review
AU - Falkowski, Anna
AU - Ciminata, Giorgio
AU - Manca, Francesco
AU - Bouttell, Janet
AU - Jaiswal, Nishant
AU - Farhana Binti Kamaruzaman, Hanin
AU - Hollingworth, Samantha
AU - Al-Adwan, Mariana
AU - Heggie, Robert
AU - Putri, Septiara
AU - Rana, Dikshyanta
AU - Mukelabai Simangolwa, Warren
AU - Grieve, Eleanor
N1 - Funding Information:
The pandemic has forged greater collaborative working across the healthcare system and beyond in many countries. For example, in Jordan, private–public partnerships have played an essential role in building capacity in HTA. The private sector has provided training to the Ministry of Health (MoH) and has also brought in regional experts to support the undertaking of HTA on their behalf. During the pandemic, these private–public partnerships came to the fore. Patients, regardless of their insurance status and whether they were admitted to a private or public hospital, were covered by the MoH. Such a response can help pave and accelerate the way to UHC []. Cross-sectoral partnerships, and the inclusion, co-ordination, and integration of governmental, private and NGO sectors require the responsible oversight of state authorities to shape evidence-based policy. For instance, in Nepal, though no formal HTA body presides over health policy decisions, there are numerous partnerships between foreign universities, INGOs and NGOs that has led to success of projects that promote sustainable development goals. Furthermore, the collaboration noted with the health research council in Nepal (and India) is a way of directly aligning HTA with the research and data, the latter being a well-known challenge in LMIC that often lack comprehensive and reliable local health and economic data but we acknowledge that this challenge not limited to LMIC []. Another example of a cross-sectoral partnership is that of Thanzi la Onse (Health of All) operation in southern and east Africa where universities (York, Kings College, Malawi universities), the Ministry of Health of Malawi, the Medical Research Council Uganda Research Unit, Center for Global Development, and East, Central and Southern Africa Research Community have partnered with funding from the UK Research and Innovation’s Global Challenges Research Fund for priority setting within health benefit packages.
Publisher Copyright:
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2022
Y1 - 2022
N2 - Health Technology Assessment (HTA) is a multidisciplinary tool to inform healthcare decision-making. HTA has been implemented in high-income countries (HIC) for several decades but has only recently seen a growing investment in low- and middle-income countries. A scoping review was undertaken to define and compare the role of HTA in least developed and lower middle-income countries (LLMIC). MEDLINE and EMBASE databases were searched from January 2015 to August 2021. A matrix comprising categories on HTA objectives, methods, geographies, and partnerships was used for data extraction and synthesis to present our findings. The review identified 50 relevant articles. The matrix was populated and sub-divided into further categories as appropriate. We highlight topical aspects of HTA, including initiatives to overcome well-documented challenges around data and capacity development, and identify gaps in the research for consideration. Those areas we found to be under-studied or under-utilized included disinvestment, early HTA/implementation, system-level interventions, and cross-sectoral partnerships. We consider broad practical implications for decision-makers and researchers aiming to achieve greater interconnectedness between HTA and health systems and generate recommendations that LLMIC can use for HTA implementation. Whilst HIC may have led the way, LLMIC are increasingly beginning to develop HTA processes to assist in their healthcare decision-making. This review provides a forward-looking model that LLMIC can point to as a reference for their own implementation. We hope this can be seen as timely and useful contributions to optimize the impact of HTA in an era of investment and expansion and to encourage debate and implementation.
AB - Health Technology Assessment (HTA) is a multidisciplinary tool to inform healthcare decision-making. HTA has been implemented in high-income countries (HIC) for several decades but has only recently seen a growing investment in low- and middle-income countries. A scoping review was undertaken to define and compare the role of HTA in least developed and lower middle-income countries (LLMIC). MEDLINE and EMBASE databases were searched from January 2015 to August 2021. A matrix comprising categories on HTA objectives, methods, geographies, and partnerships was used for data extraction and synthesis to present our findings. The review identified 50 relevant articles. The matrix was populated and sub-divided into further categories as appropriate. We highlight topical aspects of HTA, including initiatives to overcome well-documented challenges around data and capacity development, and identify gaps in the research for consideration. Those areas we found to be under-studied or under-utilized included disinvestment, early HTA/implementation, system-level interventions, and cross-sectoral partnerships. We consider broad practical implications for decision-makers and researchers aiming to achieve greater interconnectedness between HTA and health systems and generate recommendations that LLMIC can use for HTA implementation. Whilst HIC may have led the way, LLMIC are increasingly beginning to develop HTA processes to assist in their healthcare decision-making. This review provides a forward-looking model that LLMIC can point to as a reference for their own implementation. We hope this can be seen as timely and useful contributions to optimize the impact of HTA in an era of investment and expansion and to encourage debate and implementation.
KW - Decision making
KW - Health Technology Assessment
KW - Low and Middle Income Countries
UR - http://www.scopus.com/inward/record.url?scp=85136473136&partnerID=8YFLogxK
U2 - 10.1080/20477724.2022.2106108
DO - 10.1080/20477724.2022.2106108
M3 - Review article
C2 - 35950264
AN - SCOPUS:85136473136
SN - 2047-7724
VL - 117
SP - 104
EP - 119
JO - Pathogens and Global Health
JF - Pathogens and Global Health
IS - 2
ER -